Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | KRYS | NUVL | ||
| Company | Eidos Therapeutics Inc | Krystal Biotech Inc | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 181.82 | 75.53 | ||
| High | 128.49 | 183.37 | 75.56 | ||
| Low | 116.83 | 177.36 | 71.34 | ||
| Last | 122.21 | 177.61 | 73.00 | ||
| Change | -6.23 | -4.66 | -2.51 | ||
| % Change | -4.85% | -2.56% | -3.32% | ||
| Volume | 335,500 | 331,300 | 312,800 | ||
| 20-Day Average Volume | 113,985 | 679,325 | 441,395 | ||
| Previous Close | 128.44 | 182.27 | 75.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 175.99 | 77.73 | ||
| 20-Day Raw Stochastic | 36.63% | 54.96% | 32.38% | ||
| 20-Day Relative Strength | 56.42% | 55.42% | 46.94% | ||
| Weighted Alpha | +136.62 | +22.28 | +44.63 | ||
| Today's Opinion | 88% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -1.72% since 06/25/24 | -9.17% since 06/25/24 | ||
| Low | 116.83 on 01/25/21 | 176.66 on 06/26/24 | 71.34 on 07/02/24 | ||
| High | 131.08 on 01/20/21 | 188.86 on 07/01/24 | 79.99 on 06/26/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +10.97% since 05/31/24 | +11.25% since 05/31/24 | ||
| Low | 116.24 on 01/05/21 | 160.32 on 06/05/24 | 65.10 on 06/03/24 | ||
| High | 132.54 on 01/04/21 | 191.78 on 06/13/24 | 83.35 on 06/06/24 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +0.40% since 04/02/24 | -0.57% since 04/02/24 | ||
| Low | 69.38 on 10/30/20 | 144.00 on 05/06/24 | 61.79 on 04/19/24 | ||
| High | 132.54 on 01/04/21 | 191.78 on 06/13/24 | 83.35 on 06/06/24 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +42.13% since 01/02/24 | -4.07% since 01/02/24 | ||
| Low | 38.44 on 07/31/20 | 107.50 on 02/22/24 | 61.79 on 04/19/24 | ||
| High | 132.54 on 01/04/21 | 191.78 on 06/13/24 | 89.39 on 03/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 5,072,187 | 4,712,588 | ||
| Shares Outstanding, K | 38,873 | 28,558 | 64,556 | ||
| Annual Sales | 26,690,000 | 50,700,000 | 0 | ||
| Annual Net Income | -37,840,000 | 10,930,000 | -126,220,000 | ||
| Last Quarter Sales | 130,000 | 45,250,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | 930,000 | -44,480,000 | ||
| 60-Month Beta | -0.16 | 0.84 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.03 on 05/06/24 | -0.69 on 05/09/24 | ||
| Latest Earnings Date | 02/24/21 | 08/05/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||